Weave AutoIND / regulatory automation

Regulatory, medical writing and pharmacovigilance Deployment Vendor source

Disclosed: Sep 2026 Verified: September 28, 2026 Partners: Weave Bio

Takeda is deploying Weave Bio's AI regulatory-writing platform across 14 programs. Use started with IND drafting and has grown to health-authority question responses.

97% reduction in time to first draft in the IND phase (joint study) vendor claim

Source

Vendor Archived copy ↗